A new Alzheimer’s drug is hitting the market—the first with clear-cut evidence that it can slow, by several months, the mind-robbing disease.
EXPLAINER: New drug slows Alzheimer’s but comes with caveats

Corporate businessmen working on tablet at office
Comments